Essential Oncology for Health Professionals

Autor Pandha, Hardev, Lemoine, Nick
Vydáno 1995

PBX3 in Cancer

Autor Morgan, Richard, Pandha, Hardev S
Vydáno v Cancers (Basel) (2020)

Recent developments and current status of gene therapy using viral vectors in the United Kingdom

Autor Relph, Kate, Harrington, Kevin, Pandha, Hardev
Vydáno 2004

Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calciu...

Autor Morgan, Richard, Fairfax, Benjamin, Pandha, Hardev S
Vydáno 2006

HG-38 INHIBITING PBX-HOX BINDING IN PAEDIATRIC GLIOMA STEM CELLS AS A NOVEL THERAPEUTIC TREATMENT IN GLIOBLASTOMA

Autor Rogers, William, Morgan, Richard, Pandha, Hardev
Vydáno v Neuro Oncol (2016)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma

Autor Iyer, Ridhima, Montgomery, Bruce, Pandha, Hardev S.
Vydáno v Indian J Urol (2017)

Oncolytic Viruses: Time to Compare, Contrast, and Combine?: 5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009

Autor Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Vile, Richard
Vydáno 2009

Basaloid carcinoma of the prostate: A literature review with case report

Autor Tuan, Jeffrey, Pandha, Hardev, Corbishley, Cathy, Khoo, Vincent
Vydáno 2012

Live viruses to treat cancer

Autor Donnelly, Oliver, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
Vydáno 2013

Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium

Autor Michael, Agnieszka, John, Justin, Meyer, Brendan, Pandha, Hardev
Vydáno v ScientificWorldJournal (2010)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response

Autor Annels, Nicola E., Simpson, Guy R., Pandha, Hardev
Vydáno v Front Oncol (2020)

Kinase Regulation of HOX Transcription Factors

Autor Primon, Monika, Hunter, Keith D., Pandha, Hardev S., Morgan, Richard
Vydáno v Cancers (Basel) (2019)

The Hitchhiker's Guide to Virotherapy

Autor Donnelly, Oliver, Vile, Richard, Pandha, Hardev, Harrington, Kevin, Melcher, Alan
Vydáno 2012

Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease

Autor Maylin, Zoe R, Nicolescu, Radu CB, Pandha, Hardev, Asim, Mohammad
Vydáno v Transl Oncol (2021)

Targeting HOX and PBX transcription factors in ovarian cancer

Autor Michael Agnieszka, Harrington Kevin J, Plowright Lynn, Morgan Richard, Pandha Hardev S
Vydáno 2010-03-01

Targeting HOX and PBX transcription factors in ovarian cancer

Autor Morgan, Richard, Plowright, Lynn, Harrington, Kevin J, Michael, Agnieszka, Pandha, Hardev S
Vydáno 2010

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Autor Simpson, Guy R, Relph, Kate, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
Vydáno v Oncolytic Virother (2016)

Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma

Autor Punia, Natasha, Primon, Monika, Simpson, Guy R., Pandha, Hardev S., Morgan, Richard
Vydáno v Sci Rep (2019)

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

Autor Anesti, Anna-Maria, Simpson, Guy R, Price, Toby, Pandha, Hardev S, Coffin, Robert S
Vydáno 2010

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

Autor Pandha, Hardev, Harrington, Kevin, Ralph, Christy, Melcher, Alan, Grose, Mark, Shafren, Darren
Vydáno v J Immunother Cancer (2015)